| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
|
| | auramycin B Basic information |
| Product Name: | auramycin B | | Synonyms: | auramycin B;1-Naphthacenecarboxylic acid, 4-[[[2''',3''-anhydro]-O-3,6-dideoxy-α-L-erythro-hexopyranos-4-ulos-1-yl-(1→4)-O-2,6-dideoxy-α-L-lyxo-hexopyranosyl-(1→4)-2,3,6-trideoxy-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-2-methyl-6,11-dioxo-, methyl ester, (1R,2R,4S)-... | | CAS: | 78173-91-8 | | MF: | C41H49NO15 | | MW: | 795.83 | | EINECS: | | | Product Categories: | | | Mol File: | 78173-91-8.mol |  |
| | auramycin B Chemical Properties |
| Melting point | 161°C | | Boiling point | 748.77°C (rough estimate) | | density | 1.2495 (rough estimate) | | refractive index | 1.6220 (estimate) | | pka | 6.41±0.70(Predicted) | | color | Yellow powder |
| Toxicity | dni-mus:leu 750 nmol/L JANTAJ 34,1596,81 |
| | auramycin B Usage And Synthesis |
| Uses | Auramycin B, an anthracycline antibiotic that shows marked antibacterial activity against Gram-positive bacteria. Auramycin B also exhibits antitumor activity against P388 and L1210 leukemia in mice[1]. | | Safety Profile | Poison by intraperitoneal route.Mutation data reported. When heated to decomposition itemits toxic fumes of NOx. | | References | [1] Fujiwara A, et al. New anthracycline antibiotics, auramycins and sulfurmycins. I. Isolation and characterization of auramycins A and B, and sulfurmycins A and B. J Antibiot (Tokyo). 1982 Feb;35(2):164-75. DOI:10.7164/antibiotics.35.164 |
| | auramycin B Preparation Products And Raw materials |
|